No profile data available.
Cardiac Biotech Solutions Inc. (CBSC) is a healthcare company in the heart treatment equipment industry, based in Las Vegas, United States, with about 5 full-time employees.
It reported revenue of $41,397 for fiscal year 2025, down 69.3% from fiscal year 2024, and net income of -$1.68 million. In Q1 2026 (the quarter ended June 30, 2025) revenue was $45,072, up 289.3% from a year before. Its market capitalization was $5.97 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
, through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc.
Cardiac Biotech Solutions reported $41,397 in revenue for fiscal year 2025, down 69.3% from $135,055 in fiscal year 2024. In Q1 2026 revenue was $45,072.
$5.97 million as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include HeartBeam, Inc. (BEAT), Picard Medical, Inc. (PMI), HeartSciences Inc. (HSCS), Adagio Medical Holdings, Inc. (ADGM).